Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin Rural Emergency Hospitals — Transformative Change or Limited Impact? [PODCAST] - (Posted On Wednesday, March 22, 2023) Recent Developments to the 340B Drug Pricing Program [PODCAST] - (Posted On Thursday, December 15, 2022) New Data Available Under the Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, November 17, 2022) Genesis Healthcare and the 340B Program Patient Definition [PODCAST] - (Posted On Tuesday, August 09, 2022) Supreme Court Issues Decision Favorable to Hospitals on 340 B Payment Reduction: What to Do Next - (Posted On Tuesday, June 21, 2022) Medicare Reimbursement for Community Hospital Residency Programs [PODCAST] - (Posted On Monday, January 31, 2022) 2022 OPPS Final Rule Overview: CMS Finalizes Policies on 340B, Hospital Price Transparency, and Inpatient-Only List - (Posted On Monday, November 08, 2021) An Update on the CMS Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, October 21, 2021) CMS Proposes to Increase Penalties for Hospital Price Transparency Noncompliance - (Posted On Thursday, July 22, 2021) 340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case - (Posted On Thursday, July 08, 2021) Pagination Page 1 Next page Next › Current Legal Analysis Walking Off the Job in Construction's Economic Downcycle by: Chad V. Theriot Patent Derivation Proceedings Offer a First-to-File Exception – Don’t Take the Bait by: Gregory A. Lewis , Anita C. Marinelli Why Confidential Witness Allegations Fail the Tellabs Test in the District of Massachusetts by: Melanie A. Conroy False Claims Act: DOJ Doubles Down on Duty Evasion Outside the Traditional Trade Enforcement Scheme by: Lydia C. Pardini , Deanna Tanner Okun Made in America: End-to-End Guide to Developing Your U.S. Manufacturing Footprint Introduction by: Andrew J. Wronski This Week in 340B: August 26 – September 1, 2025 by: Emily J. Cook , Reuben Bank Real Smart: The Industrial Sector's Resilience [Video] by: Spencer B. Kallick Healthcare Preview for the Week of: September 2, 2025 by: Debra Curtis , Kayla Holgash COVID-19 Business Interruption Cases Reach the End of the Road, with Mixed Results by: Wystan M. Ackerman Hawai’i Supreme Court Applies Pollution Exclusion in CGL Case Involving Climate Change by: Wystan M. Ackerman Appraisal First, or Else by: Scott T. Garosshen Jurisdictional Quickdraw: How to Avert a State-Court Remand Post-Coinbase by: Scott T. Garosshen Action Required for Manufacturers of Connected Devices: Challenges Under the EU Data Act by: Dr. Viola Bensinger , Dr. Paul Dürr The Global Stablecoin: Stablecoin Regulatory Framework in Singapore by: Lucas Nicolet-Serra , Edward M. Bennett CMS Proposes Several Changes Affecting Telehealth Services in the 2026 Medicare Physician Fee Schedule Proposed Rule by: Danielle H. Tangorre , Conor O. Duffy Upcoming Events Sep 15-16 2025 US General Counsel Summit Sep 15-16 2025 Chief Litigation Officer Summit Sep 29-30 2025 Intellectual Property Law Institute 2025 - New York Oct 20-21 2025 Intellectual Property Law Institute 2025 - California Print
